Crawford Investment Counsel Inc. Decreases Stake in Amdocs Limited $DOX

Crawford Investment Counsel Inc. decreased its position in shares of Amdocs Limited (NASDAQ:DOX) by 4.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 910,884 shares of the technology company’s stock after selling 40,608 shares during the quarter. Crawford Investment Counsel Inc. owned approximately 0.84% of Amdocs worth $73,335,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Pzena Investment Management LLC boosted its position in shares of Amdocs by 82.6% during the 4th quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock valued at $969,100,000 after acquiring an additional 5,443,766 shares during the last quarter. LSV Asset Management boosted its position in shares of Amdocs by 0.8% during the 4th quarter. LSV Asset Management now owns 3,678,532 shares of the technology company’s stock valued at $296,159,000 after acquiring an additional 29,829 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Amdocs by 1.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock valued at $253,786,000 after acquiring an additional 54,676 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of Amdocs by 3.0% during the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock valued at $258,583,000 after acquiring an additional 91,900 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Amdocs by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock valued at $251,602,000 after acquiring an additional 9,207 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Up 0.2%

Shares of DOX opened at $56.01 on Wednesday. The firm has a market cap of $6.05 billion, a P/E ratio of 11.20, a price-to-earnings-growth ratio of 0.97 and a beta of 0.38. Amdocs Limited has a 12-month low of $55.27 and a 12-month high of $95.41. The company’s 50-day moving average price is $62.76 and its 200 day moving average price is $70.43. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. The company had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.78 earnings per share. On average, sell-side analysts forecast that Amdocs Limited will post 6.56 earnings per share for the current year.

Amdocs Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.569 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.28 dividend on an annualized basis and a yield of 4.1%. Amdocs’s dividend payout ratio is 45.60%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Stifel Nicolaus reduced their price objective on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Cfra lowered shares of Amdocs to a “sell” rating in a report on Thursday, May 14th. Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Amdocs in a report on Friday, May 8th. Three investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $86.67.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.